テルミサルタンとヒトチオプリンSメチルトランスフェラーゼの結合ダイナミクスと相互作用に関するメカニズム的洞察
Archana Vakkayil1, Deepthi Jose2, Tom Skaria1
1Department of Bioscience and Engineering, National Institute of Technology Calicut, Calicut, Kerala, India.
Journal of pharmaceutical sciences
|August 30, 2025
まとめ
テルミサルタン薬は,免疫抑制剤の処理に不可欠な酵素であるチオプリンSメチルトランスファーゼ (TPMT) と危険な相互作用を起こす可能性があります. この相互作用は,両方の薬を服用している患者で重篤な合併症を引き起こす可能性があります.
科学分野:
- 生物化学
- 薬理学について
- 薬物の代謝
背景:
- チオピュリンSメチルトランスフェラーゼ (TPMT) は,自己免疫疾患および移植拒絶症で使用されるチオピュリン薬の不活性化に不可欠です.
- TPMTの活動が低下すると 骨髄の重度の抑制と死亡が起こり,FDAが推奨する遺伝子検査が実施されます.
- テルミサルタンは,広く処方されている抗高血圧薬です.
研究 の 目的:
- ヒトのTPMTと抗高血圧薬テルミサタンとの潜在的非標的相互作用を調査する.
- このような相互作用の背後にある分子メカニズムを明らかにする.
主な方法:
- テルミサタンとTPMTの相互作用をシミュレートするために,包括的な分子モデリングが採用されました.
- 結合モード,アクティブサイトアコモダーション,相互作用の相性分析.
主要な成果:
- テルミサルタンはTPMTの活性部位にバイサブストラットのような方法で結合することを明らかにした.
- この結合はコファクターとチオプリン基質の両方の部位を遮断する.
- テルミサルタンは,その天然の共同因子よりも,TPMTに対する強い結合親和性を示した.
結論:
- テルミサルタンはTPMTと相互作用し,その酵素活性を抑制する可能性があります.
- この相互作用は,テルミサタンとチオプーリンの併用に意味を持つ,以前未知のメカニズムを表しています.
- テルミサルタンとTPMTの相互作用の臨床的意義を評価するために,チオプリン免疫抑制剤を服用している患者において,さらなる研究が不可欠である.
関連する概念動画
Protein-Drug Binding: Mechanism and Kinetics
924
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
924
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
Telomeres and Telomerase
24.0K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
24.0K
ATP Synthase: Mechanism
15.1K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.1K
Factors Affecting Protein-Drug Binding: Drug Interactions
272
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
272


